License HUB Organoid Technology

organoid technology

License HUB Organoid Technology

Patient in the lab®: downscaling patient-derived organoid screening

organoid screening

Patient in the lab®: downscaling patient-derived organoid screening

René Overmeer, Head of Assay Development and Automation HUB Organoids

Model human disease and identify predictive biomarkers of response

organoid screening

Model human disease and identify predictive biomarkers of response

Robert Vries, CEO HUB Organoids

Modelling human inflammation “in a dish”

inflammatory disease

Modelling human inflammation “in a dish”

Sylvia Boj, CSO HUB Organoids

Tumor organoids

oncology

Tumor organoids

HUB Organoids as unique tools for personalized medicine

personalised medicine

HUB Organoids as unique tools for personalized medicine

Robert Vries, CEO HUB Organoids

HUB Organoids as models for precision medicine, in vitro diagnostics, and infectious disease

infectious disease

HUB Organoids as models for precision medicine, in vitro diagnostics, and infectious disease

Robert Vries, CEO & Sylvia Boj, CSO HUB Organoids; Ryan Conder, STEMCELL Technologies

cystic fibrosis

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation

J Cyst Fibros | Sep 2021 | Clinical trial

oncology

Establishment of Pancreatic Organoids from Normal Tissue and Tumors

STAR Protocols, Cell | December 2020

X

Have any questions?

contact us